Bio-Rad Laboratories (BIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 2,311,659 | 2,289,415 | 2,160,153 | 2,068,172 | 2,019,441 |
| Cost of Goods | 1,054,663 | 1,066,264 | 972,450 | 929,744 | 897,771 |
| Gross Profit | 1,256,996 | 1,223,151 | 1,187,703 | 1,138,428 | 1,121,670 |
| Operating Expenses | 1,027,998 | 1,326,756 | 1,068,903 | 1,083,454 | 955,733 |
| Operating Income | 229,661 | -103,341 | 119,250 | 55,718 | 166,708 |
| Interest Expense | 23,416 | 23,962 | 23,014 | 23,380 | 21,692 |
| Other Income | 2,054,836 | 639,962 | 1,569 | 9,222 | 831 |
| Pre-tax Income | 2,261,081 | 512,659 | 97,805 | 41,560 | 145,847 |
| Income Tax | 502,406 | 147,045 | -24,444 | 15,560 | 36,608 |
| Net Income Continuous | 1,758,675 | 365,614 | 122,249 | 26,000 | 109,239 |
| Net Income | $1,758,675 | $365,614 | $122,249 | $26,000 | $109,239 |
| EPS Basic Total Ops | 58.93 | 12.25 | 4.12 | 0.88 | 3.74 |
| EPS Basic Continuous Ops | 58.93 | 12.25 | 4.12 | 0.88 | 3.74 |
| EPS Diluted Total Ops | 58.27 | 12.10 | 4.07 | 0.88 | 3.71 |
| EPS Diluted Continuous Ops | 58.27 | 12.10 | 4.07 | 0.88 | 3.71 |
| EPS Diluted Before Non-Recurring Items | 7.06 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $229,661 | $-103,341 | $119,250 | $55,718 | $166,708 |